Xylose

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

Xylose EUROPEAN PHARMACOPOEIA 11.

Flow rate : 1.0 mL/min.


Detection : spectrophotometer at 220 nm.
Injection : 10 μL.
Relative retention with reference to xylometazoline (retention
time = about 7.2 min): impurity A = about 0.79.
C. [4-(1,1-dimethylethyl)-2,6-dimethylphenyl]acetonitrile,
System suitability : reference solution (b) :
– resolution : minimum 2.5 between the peaks due to
impurity A and xylometazoline.
Limits :
– impurity A : not more than the area of the corresponding
peak in the chromatogram obtained with reference
solution (c) (0.2 per cent) ; D. 1-(1,1-dimethylethyl)-3,5-dimethylbenzene,
– unspecified impurities : for each impurity, not more than the
area of the principal peak in the chromatogram obtained
with reference solution (a) (0.10 per cent) ;
– total : not more than 5 times the area of the principal peak
in the chromatogram obtained with reference solution (a) E. ethane-1,2-diamine mono(4-methylbenzenesulfonate),
(0.5 per cent) ;
– disregard limit : 0.5 times the area of the principal peak in
the chromatogram obtained with reference solution (a)
(0.05 per cent).
Loss on drying (2.2.32) : maximum 0.5 per cent, determined
on 1.000 g by drying in an oven at 105 °C.
F. [4-(1,1-dimethylethyl)-2,6-dimethylphenyl]acetic acid.
Sulfated ash (2.4.14) : maximum 0.1 per cent, determined on
1.0 g.
01/2017:1278
ASSAY
Dissolve 0.200 g in 25 mL of anhydrous acetic acid R and add
10 mL of acetic anhydride R. Titrate with 0.1 M perchloric
acid, determining the end-point potentiometrically (2.2.20).
1 mL of 0.1 M perchloric acid is equivalent to 28.08 mg XYLOSE
of C16H25ClN2.
Xylosum
STORAGE
Protected from light.

IMPURITIES
Specified impurities : A.
Other detectable impurities (the following substances would, C5H10O5 Mr 150.1
if present at a sufficient level, be detected by one or other of [58-86-6]
the tests in the monograph. They are limited by the general
acceptance criterion for other/unspecified impurities and/or DEFINITION
by the general monograph Substances for pharmaceutical use D-Xylopyranose.
(2034). It is therefore not necessary to identify these impurities
for demonstration of compliance. See also 5.10. Control of CHARACTERS
impurities in substances for pharmaceutical use) : B, C, D, E, F. Appearance : white or almost white, crystalline powder or
colourless needles.
Solubility : freely soluble in water, soluble in hot ethanol
(96 per cent).
IDENTIFICATION
First identification : A.
Second identification : B, C.
A. N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-2,6- A. Infrared absorption spectrophotometry (2.2.24).
dimethylphenyl]acetamide, Preparation : discs.
Comparison : xylose CRS.
B. Thin-layer chromatography (2.2.27).
Solvent mixture : water R, methanol R (2:3 V/V).
Test solution. Dissolve 10 mg of the substance to be
examined in the solvent mixture and dilute to 20 mL with
the solvent mixture.
Reference solution (a). Dissolve 10 mg of xylose CRS in
B. 2-(chloromethyl)-5-(1,1-dimethylethyl)-1,3- the solvent mixture and dilute to 20 mL with the solvent
dimethylbenzene, mixture.

4410 See the information section on general monographs (cover pages)


www.webofpharma.com
EUROPEAN PHARMACOPOEIA 11.0 Xylose

Reference solution (b). Dissolve 10 mg of fructose R, 10 mg TESTS


of glucose R and 10 mg of xylose R in the solvent mixture Solution S. Dissolve 10.0 g in carbon dioxide-free water R and
and dilute to 20 mL with the solvent mixture. dilute to 100 mL with the same solvent.
Plate : TLC silica gel plate R.
Mobile phase : water R, methanol R, anhydrous acetic acid R, Appearance of solution. Solution S is clear (2.2.1) and
ethylene chloride R (10:15:25:50 V/V/V/V) ; measure the colourless (2.2.2, Method II).
volumes accurately since a slight excess of water produces Acidity or alkalinity. To 50 mL of solution S add 0.3 mL of
cloudiness. phenolphthalein solution R1. The solution is colourless. Not
Application : 2 μL ; thoroughly dry the points of application. more than 0.2 mL of 0.1 M sodium hydroxide is required to
Development : over a path of 15 cm. change the colour of the indicator to pink.
Drying : in a current of warm air. Specific optical rotation (2.2.7) : + 18.5 to + 19.5 (dried
Detection : spray with a 5 g/L solution of thymol R in a substance).
mixture of 5 volumes of sulfuric acid R and 95 volumes
of ethanol (96 per cent) R. Heat in an oven at 130 °C for Dissolve 10.0 g in 80 mL of water R, add 1 mL of dilute
10 min. ammonia R2 and dilute to 100.0 mL with water R. Allow to
stand for 30 min.
System suitability : reference solution (b):
– the chromatogram shows 3 clearly separated spots. Chlorides (2.4.4) : maximum 330 ppm.
Results : the principal spot in the chromatogram obtained Dilute 1.5 mL of solution S to 15 mL with water R.
with the test solution is similar in position, colour and size
to the principal spot in the chromatogram obtained with Loss on drying (2.2.32) : maximum 0.5 per cent, determined
reference solution (a). on 1.000 g by drying in an oven at 105 °C at a pressure not
C. Dissolve 0.1 g in 10 mL of water R. Add 3 mL of exceeding 0.7 kPa.
cupri-tartaric solution R and heat. An orange or red Sulfated ash (2.4.14): maximum 0.1 per cent, determined on
precipitate is formed. 1.0 g.

General Notices (1) apply to all monographs and other texts 4411
www.webofpharma.com

You might also like